All 52 GLP-1 providers, side-by-side

Pros

• +Specializes in oral compounded semaglutide, the go-to for patients who absolutely won't do injections
• +Needle-free oral semaglutide tablets from $99/mo, one of the lowest oral entry prices in the table, with oral tirzepatide ($199/mo) and auto-refill injectables ($149–$199/mo) if you switch formats
• +Clear educational content about oral semaglutide absorption and how to maximize effectiveness

Cons

• −Compounded only, no brand-name Wegovy or Zepbound. Oral tablets carry a bioavailability caveat vs injections, so results may come slower on the needle-free formats.
• −Oral compounded semaglutide has lower bioavailability than injectable forms, so plan for potentially slower or smaller weight-loss results

Pros

• +Same-day physician consults, one of the few platforms offering telehealth appointments the same day you apply
• +80,000+ customer base with 4.9-star Trustpilot rating provides strong social proof of reliability
• +100% money-back guarantee if your consultation determines you don't qualify for GLP-1 treatment

Cons

• −Standard semaglutide pricing is $289/mo, above competitors at $99-199/mo; the TAKEOFF 3-month entry (about $99/mo first month) and annual plans from $99/mo bring the effective rate down
• −$29.99 shipping fee per order where most competitors ship free; factor it into your monthly total
• −A $50 non-refundable cancellation fee applies after intake approval; decide before the consult, and cancel at least 48 hours ahead of your monthly processing date

Pros

• +Success by Sesame program launched 2026, $59/mo on a 3/6/12-month plan, bundles labs, unlimited messaging, and provider choice
• +Brand-name cash pricing is competitive, Wegovy pen $199 intro / $349 ongoing, Zepbound vial $299, Wegovy pill $149
• +Foundayo (Lilly's FDA-approved oral GLP-1) available as of April 2026 at $149/mo

Cons

• −Two distinct products (pay-per-visit vs the Success membership) sit side by side, so decide which you're buying before checkout
• −The $59/mo Success by Sesame rate requires a 3-month minimum commitment; month-to-month is available at $99/mo if you don't want to commit
• −Compounded meds are de-emphasized in the current marketing, the platform now leads with FDA-approved brand-name paths

Pros

• +True all-inclusive pricing, $280/mo covers medication, consultations, shipping, and pharmacy fees with no add-ons
• +Clear dose-based pricing published on their site, no surprise cost increases when titrating up
• +Fast pharmacy fulfillment: most orders ship within 48 hours of provider approval

Cons

• −Compounded medications only, no brand-name Wegovy, Zepbound, or Ozempic on the menu
• −The $280/mo flat rate sits above Henry Meds ($199) and TrimRx ($149); Direct Meds' own sublingual drops at $179 are the budget path if the premium stings

Pros

• +$149/mo all-inclusive for compounded semaglutide, one of the lowest prices for a full-service program
• +Onboarding takes under 15 minutes with same-day provider review for most applications
• +Free medication replacement if your shipment is lost or damaged in transit

Cons

• −Compounded semaglutide is the only medication, no tirzepatide and no brand-name options. Pick TrimRx only if you already know semaglutide is your drug.
• −No insurance billing and no superbill for out-of-network reimbursement, so treat the $149/mo as a pure cash-pay price

Pros

• +GLP-1 from $49 your first month, then $212/mo, with access to both brand-name and compounded; wafers as low as $84/mo on the 6-month plan
• +Offers combination therapies (GLP-1 + B12, GLP-1 + NAD+) for patients wanting enhanced protocols
• +Quick asynchronous consultations, most patients approved within 24 hours without video calls

Cons

• −Check-ins are patient-initiated rather than scheduled; portal requests are usually answered within 24 hours, but you drive the cadence
• −No insurance billing, and customer support runs business days only, no weekends

Pros

• +Clinical-service-only path to brand Wegovy and Zepbound at $99/mo, prescription goes to patient's pharmacy (you fill separately using insurance or cash)
• +Steep multi-month commitment discounts on compounded sema, $158/mo on 12-month plan ($1,900 upfront) vs $249/mo month-to-month
• +Same price at all dose levels for compounded, no cost escalation as you titrate up

Cons

• −The $99/mo Wegovy/Zepbound tier is the clinical service only. Medication is billed separately at your pharmacy (can be $1,000+/mo cash without insurance). Choose this tier when your insurance covers the drug itself.
• −The best compounded rates require prepayment: $1,050 upfront for 6 months, $1,900 for 12. Start at $249 month-to-month if you want to test fit first.
• −The intake is a 90-second quiz. Fast, but lighter screening than competitors with full medical intakes. Better suited to patients who already know GLP-1 basics.

Pros

• +Simplest all-in pricing: $199/mo flat covering medication, consultation, and free shipping, zero hidden fees
• +48-hour medication shipping, among the fastest fulfillment times in the industry
• +No doctor visit required in most states, maximally convenient for patients who don't want appointments

Cons

• −No video or phone consultation in most states; providers review your intake asynchronously. Maximum convenience, but pick a platform with regular check-ins if you want closer clinical oversight.
• −Headquarters, founding date, and pharmacy partners aren't publicly disclosed. Ask support which pharmacy fills your prescription before ordering.
• −The independent review footprint is still thin, which makes patient satisfaction claims hard to verify. Treat month one as your own trial run.

Pros

• +Industry-leading delivery speed, most patients receive medication within 2-3 days of enrollment
• +$199/mo is competitively priced for an all-inclusive compounded program with good support
• +Streamlined onboarding with no video call, approved and shipped faster than most competitors

Cons

• −The core $199 program is compounded semaglutide and tirzepatide; brand-name access runs through a separate $99/mo pathway subscription with medication billed at pharmacy rates on top
• −Newer company (founded 2024) with limited long-term track record and outcome data; the 4.6/5 Trustpilot rating across 766 reviews is the strongest early evidence available
• −No insurance billing and no FSA/HSA superbills currently available

Pros

• +One of the few compounded providers offering both oral tablets and injectable semaglutide
• +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
• +Sleek onboarding experience with clear progress tracking through their patient portal

Cons

• −No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
• −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag

Pros

• +Price Lock Guarantee ensures your monthly rate never increases even as your GLP-1 dose escalates, a genuine differentiator
• +Competitive pricing at $149-$179/mo for compounded semaglutide with free shipping included
• +Access to 600+ board-certified doctors with unlimited clinician messaging at no additional cost

Cons

• −Cash-pay only, no insurance accepted. If your plan covers GLP-1s, price that route first; HSA/FSA cards do work here
• −Select states only, not all 50, and the exact list isn't published. Confirm your state during the intake quiz before paying
• −Compounded medications only, no brand-name GLP-1 option on the menu

Pros

• +Two named board-certified doctors (Dr. Michael Wasef MD and Dr. Andrew Sakla DO), most compounded GLP-1 providers don't publicly name their prescribers.
• +4.6 stars across 1,065 verified Trustpilot reviews, 84% give 5 stars. Top complimented theme: customer service.
• +Cheap if you commit: $146/mo for compounded semaglutide on the 6-month plan.

Cons

• −Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro.
• −The $146/mo price requires a 6-month upfront commitment (month-to-month is meaningfully more expensive). The Klarna/Affirm/Afterpay financing exists to spread exactly that upfront cost.
• −No live tele-visit option, only async review. Faster, but less depth if you have a complex health history and want a provider you can talk to.

Pros

• +Oral dissolving tablets for BOTH semaglutide AND tirzepatide, one of the few platforms with needle-free tirzepatide
• +Free expedited shipping included with all orders
• +24/7 support with unlimited messaging, no per-visit fees for follow-up questions or dose adjustments

Cons

• −Registered at a Casper, WY address with limited independent reviews. Verify pharmacy partners and provider credentials before enrolling.
• −Brand-name pricing ($499-947/mo) is very high compared to direct manufacturer programs like LillyDirect. Use SynergyRx for its compounded oral tablets; source brand-name directly if that's what you need.
• −Company history, founding date, and ownership structure are not publicly disclosed. Ask support for pharmacy and prescriber details upfront.

Pros

• +Oral dissolving tablets exclusively, zero injections for any GLP-1 option
• +Publicly traded on NASDAQ (MGRX), SEC-required financial transparency that private competitors can't match
• +Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment

Cons

• −Oral semaglutide at $299/mo runs 2-3x injectable alternatives ($99-149/mo). The premium only makes sense if needles are a hard no for you.
• −Early-stage public company with limited revenue; the same SEC filings that provide transparency also show the financial uncertainty reflected in the stock.
• −Oral tablets are the only format, with no injectable option if you want higher bioavailability. If you may switch to injections later, pick a platform that carries both.

Pros

• +$133/mo for compounded semaglutide is among the cheapest entries on the market, Sesame Care ($99) is lower, but Oak undercuts most mid-tier platforms
• +No-subscription model, patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
• +Compounded tirzepatide at $199/mo is competitively priced for a GLP-1+GIP dual agonist

Cons

• −Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare sells Wegovy direct at $349/mo and LillyDirect has Zepbound at $299/mo. Use Oak for its compounded tiers and buy brand-name direct
• −No published lab panels and no specialty (obesity medicine) physicians disclosed, clinical oversight is lighter than lab-driven platforms
• −The 'up to 50% cheaper than competitors' marketing claim is unverified and inconsistent, judge Oak on its posted prices, which are genuinely low, not on the slogan

Pros

• +Both oral pill AND injectable GLP-1 options at the same flat $199/mo rate, flexibility to switch formats
• +Named physician leadership (Dr. Ana Lisa Carr MD, Dr. Kelly Tenbrink MD) adds accountability
• +Same price at every dose with no hidden fees, simple, transparent billing

Cons

• −Founding date, headquarters, and pharmacy partners are not published. Ask which pharmacy fills your prescription before you order.
• −Independent reviews are still very limited, so satisfaction and reliability are hard to verify. The named physician leadership is the main trust signal to weigh.
• −Cash-pay only: no insurance accepted, and HSA/FSA eligibility isn't disclosed. Budget the $199/mo as a full out-of-pocket cost.

Pros

• +Compounded GLP-1 available in BOTH injectable AND oral dissolving tablet formats, semaglutide and tirzepatide each in two formats, broader format menu than most compounded-only platforms
• +10% weight-loss money-back guarantee: patients who don't lose at least 10% of baseline weight after 16 weeks of medication adherence may be eligible for refund of up to four months of program fees (verified weight documentation required)
• +Competitive entry pricing, $147/mo compounded semaglutide and $249/mo compounded tirzepatide put Wellorithm near the cheaper end of the compounded market

Cons

• −Founding year, corporate ownership, and named prescribers are NOT publicly disclosed, and the only address listed is a German one (Berlin, DE 81566), unusual for a platform serving US patients; if disclosed leadership matters to you, weigh this first
• −49 states only, service is unavailable in Louisiana and outside the United States
• −Billing runs on a 28-day recurring cycle and payments are non-refundable once processed, with no proration for partial months; cancel before your next cycle processes to avoid paying for an unused month

Pros

• +Active insurance coordination, Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
• +10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill), the widest formulary of any platform
• +Typical insured copay of ~$30/mo for most members, dramatically lower than cash-pay alternatives

Cons

• −Costs vary by insurance status and medication choice rather than one flat rate; run Found's coverage check first to see your exact copay before paying
• −The insurance navigation process adds steps compared to simple cash-pay platforms; the payoff is the ~$30 typical copay
• −Compounded medication availability may shift with FDA enforcement changes; the 10+ medication formulary lets your clinician move you to a brand-name option if it does

Pros

• +Oral tirzepatide gum is rare. Real option for needle-phobic users. (How well it absorbs vs the FDA-approved injection isn't published.)
• +Cheap first month, $99 for semaglutide or $149 for tirzepatide. Among the lowest entry prices in the category.
• +'Embody Flat' plan is $299/mo flat with no surprise increases, predictable if you pick it from the start.

Cons

• −Two plans run side by side and the switchover isn't always clear at signup: the $149 promo month steps up to $299–$399 from month 2 (Embody confirms both plans in its review replies). Pick 'Embody Flat' at signup if you want one predictable number.
• −Trustpilot rating is a polarized 3.3 / 5 across 46 reviews: 41% five-star, 24% one-star. Price is the top complaint theme, most of it tied to the promo-to-flat switchover above.
• −Embody doesn't name which pharmacy makes the medication, just 'multiple USA certified pharmacies.' This is the norm in the category, most major brands (Embody, Henry, Hims, Yucca, Eden) don't publicly name their pharmacy partners; ask support directly if provenance matters to you.

Pros

• +Flat $165/mo at all dose levels, price doesn't increase as you titrate up to maintenance doses
• +100,000+ patient base with 4.9/5 Trustpilot rating from 14,000+ reviews, strong social proof
• +Semaglutide + B12 formulation helps reduce nausea, the most common GLP-1 side effect

Cons

• −Available in 42 states, not all 50 (8 states are excluded). Check your state during signup before planning around PeterMD.
• −Not BBB accredited, and some documented complaints cite delayed medication fulfillment. Order refills ahead of your last dose rather than at the last minute.
• −PeterMD began as a testosterone replacement therapy platform; GLP-1 is an expansion, not the original core. The included video consultations give you a direct read on the clinical team.

Pros

• +No subscription required, order on demand without recurring billing commitments
• +Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
• +FSA/HSA eligible for those with health savings accounts

Cons

• −Independent reviews are very limited and the company structure is unclear, so legitimacy is hard to verify. Ask for pharmacy details first; the no-subscription model at least keeps a first order low-commitment.
• −Oral options at $299-399/mo cost significantly more than injectable alternatives. The $199 injectable semaglutide is the value pick unless tablets are a must.
• −Not available in all 50 states; availability depends on provider licensure, so check your state early in the online visit.

Pros

• +2026 Novo Nordisk partnership, FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
• +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
• +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance

Cons

• −Membership + medication are billed separately ($39 first month / $149 ongoing membership), so total both line items before comparing prices
• −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
• −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose

Pros

• +Five medication formats, the broadest compounded-GLP-1 menu in DTC telehealth, including the rare oral tirzepatide tablet that almost no competitor offers
• +$199/mo entry price for both injectable and sublingual semaglutide is competitive in the mid-tier compounded segment
• +Fast onboarding: 5–10 minute online questionnaire, physician review in 24–48 hours, medication delivered in 3–7 business days with temperature-controlled shipping

Cons

• −No brand-name FDA-approved options (Wegovy, Zepbound, Ozempic, Mounjaro), so patients who want or need an FDA-approved finished product should buy elsewhere
• −Light public disclosure: founders, executive team, medical director, and specific compounding-pharmacy partners are not named on the public site, ask support before enrolling if provenance matters to you
• −Cash-pay only, does not bill commercial insurance, Medicare, or Medicaid. HSA/FSA payments are accepted, which is the main way to soften the cost.

Pros

• +Dedicated insurance coordinators handle prior authorizations, potentially bringing brand-name GLP-1 costs to $25/mo
• +Multi-month supply options (3, 6, or 12 months), unique convenience most monthly-shipping competitors can't match
• +Both compounded and brand-name (Wegovy, Zepbound) available with clinician-guided selection

Cons

• −The $135 membership stacks on medication cost, so cash-pay semaglutide totals ~$286/mo, above average. The math works when you use the insurance coordination; cash payers should compare flat-rate platforms first.
• −Young company (founded 2023) with a relatively small review base and less track record than established platforms. Confirm the coordination promise against your own insurance plan before enrolling.
• −Prescription products are non-refundable once ordered, for any reason. Double-check dose and supply length before checkout.

Pros

• +Microdose compounded tirzepatide at $149/mo, the cheapest microdose tirz on a tracked telehealth platform; full-dose compounded tirzepatide at $179/mo (yearly plan) or $199/mo (3-month plan)
• +Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android, first-party in-treatment logging is uncommon among compounded-only platforms
• +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack

Cons

• −Brand-name Ozempic here is $1,299/mo, materially above market (NovoCare direct pricing for Wegovy is $349/mo; Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership). Buy brand-name elsewhere, Gala's value is its compounded tirzepatide.
• −Tirzepatide-only on the compounded side, compounded semaglutide is NOT offered, a narrower medication menu than peers like Maximus, Ro, or Henry Meds
• −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill

Pros

• +Competitive entry pricing: $179/mo for compounded semaglutide and $209/mo for compounded tirzepatide undercuts the mid-tier compounded average (~$199/$299) for both formats
• +Named medical advisor with disclosed credentials, Dr. Mark Rosenberg, M.D., board-certified, 25+ years anti-aging and metabolic-health experience. Most compounded-only platforms in this price tier name no medical director.
• +Multi-month bundles (1, 3, 6, 12 months) with cancel-anytime, no-monthly-membership flexibility, strong fit for users who want to lock in a price without subscription lock-in

Cons

• −Compounded-only, no brand-name FDA-approved Wegovy, Zepbound, Ozempic, Mounjaro, or oral GLP-1 (Foundayo). Patients who want an FDA-approved finished product need a different provider for that piece.
• −Pharmacy partner not publicly named, disclosures reference "licensed U.S. pharmacies" generically. If verifying 503A licensing or USP-797 accreditation upfront matters to you, use the option to specify a licensed pharmacy of your choice on intake.
• −Operating entity is Dynamo Group LLC under a brand license, NOT Bodybuilding.com directly. The "Trusted by millions since 1999" framing describes the parent retail brand; the GLP-1 program launched in 2026 and stands on its own record.

Pros

• +Lowest entry price in the market, $79.99/mo microdose semaglutide, $99.99/mo 3-month starter pack
• +GLP-1 microdosing available for BMI as low as 22, the only platform serving patients below standard obesity criteria
• +Nausea-reducing formula with added glycine and B12 to ease GLP-1 side effects

Cons

• −The $99.99/mo rate is introductory: standard dosing is $299.99/mo, with consultations billed separately at $28-35 and labs at $199-349/yr, so budget on the standard rate, not the intro
• −Compounding pharmacy partners are not disclosed, a transparency gap for a healthcare platform
• −Bulk-plan prices rise as your dose escalates; ask for the full dose-price schedule up front so total cost isn't a surprise

Pros

• +Published average weight loss outcomes: 12-15% body weight at 6 months across their patient base
• +Dedicated care coordinator assigned to each patient, not a rotating pool of providers
• +Transparent pricing: $250/mo covers medication, shipping, and all consultations

Cons

• −$250/mo all-in sits in the upper-mid range, $90 more than Willow for a similar model; the premium pays for the dedicated coordinator and published outcomes
• −No insurance accepted, and no superbill provided for FSA/HSA reimbursement

Pros

• +$99/mo compounded semaglutide on the annual plan (billed $1,188 once yearly) is among the cheapest flat recurring rates we track; tirzepatide annual is $125/mo ($1,500 yearly)
• +Flat pricing across all doses, your monthly price does not rise as your dose titrates up
• +Consult and overnight shipping included in the plan price, no add-on fees; HSA/FSA accepted, Klarna and Affirm financing available

Cons

• −Trustpilot FELL from 4.6 earlier in 2026 to 3.4 across 71 reviews, ranking #62 of 70 in its category, recurring complaints cite account closures and withheld refunds
• −Once a prescription is signed, payments are final, no pro-rating, cancelling an annual plan mid-year forfeits the remainder. Full refund is available only BEFORE the prescription is signed
• −No legal entity disclosed, the site identifies only 'Trimi Health' with no LLC/Inc suffix and no street address (New York appears only in the site's schema markup)

Pros

• +Flat pricing across all doses, $0 consult fee, free 2-day shipping, FSA/HSA accepted
• +Four compounded formats: injectable tirzepatide, injectable semaglutide, sublingual tirzepatide drops, and an explicitly priced microdose tier, format breadth most new storefronts don't offer
• +Compounding pharmacy named: VialsRX, a 503A pharmacy in Houston, TX, most competitors don't name theirs

Cons

• −The company is about 10 weeks old, telosrx.com was registered April 20, 2026. There is no operating track record to evaluate
• −Homepage claims 'Trustpilot 4.9', the actual Trustpilot page shows 4.0 from only 3 reviews (verified July 2, 2026). That mismatch is a trust problem on its own
• −No physical address published anywhere on the site

Pros

• +Four compounding pharmacies named WITH street addresses, RedRock Pharmacy (UT), Health Warehouse (KY), Precision Compounding (NY), and Triad Rx (AL), more pharmacy transparency than most competitors offer
• +Named medical group, OpenLoop Healthcare Partners, PC, most white-label storefronts name no one
• +Consult and shipping included in the monthly price ('no hidden fees'), with free expedited overnight shipping

Cons

• −Pricing contradicts itself on the SAME page: landing cards say 'Starting at $179'/mo semaglutide and $279/mo tirzepatide, but the FAQ says the program 'starts at just $249/month'. Checkout is captcha-gated, so we could not resolve which number is real, confirm the actual price at checkout before paying
• −Terms state ALL FEES NON-REFUNDABLE (in all-caps), which contradicts an undefined 'LIV Body guarantee' badge on the landing page
• −The GLP-1 program is an OpenLoop white-label: clinicians are OpenLoop Healthcare Partners, PC, the listed Des Moines HQ is OpenLoop's office, and the cancellation desk is an OpenLoop zohodesk email. The LivBody supplement brand is not the one treating you